Suchergebnisse - "Saag, Michael S"

PubPharm (27)

1

Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults : 2020 Recommendations of the International Antiviral Society-USA Panel

enthalten in: JAMA | 2020

von Saag, M. | Gandhi, R. | Hoy, J. | +13

CommentIn: JAMA. 2021 Mar 2;325(9):888-889. - PMID 33651085

2

Hepatitis C Among High-Risk Alabamians : Disease Burden and Screening Effectiveness

enthalten in: The Journal of infectious diseases | 2020

von Lee, A. | Karumberia, S. | Gilmore, A. | +5

3

HIV 101 : fundamentals of antiretroviral therapy

enthalten in: Topics in antiviral medicine | 2019

von Saag, M.

4

Antiretroviral Activity of AMD11070 (An Orally Administered CXCR4 Entry Inhibitor) : Results of NIH/NIAID AIDS Clinical Trials Group Protocol A5210

enthalten in: AIDS research and human retroviruses | 2019

von Johnson, V. | Cramer, Y. | Rosenkranz, S. | +23

5

Evolution of HIV-1 drug resistance after virological failure of first-line antiretroviral therapy in Lusaka, Zambia

enthalten in: Antiviral therapy | 2019

von Hudson, F. | Mulenga, L. | Westfall, A. | +6

6

Effective treatment of SIVcpz-induced immunodeficiency in a captive western chimpanzee

enthalten in: Retrovirology | 2017

von Barbian, H. | Jackson-Jewett, R. | Brown, C. | +13

7

Incident AIDS or Death After Initiation of Human Immunodeficiency Virus Treatment Regimens Including Raltegravir or Efavirenz Among Adults in the United States

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2017

von Cole, S. | Edwards, J. | Hall, H. | +9

ErratumIn: Clin Infect Dis. 2017 Oct 15;65(8):1431-1433. - PMID 29017252

8

Once-daily maraviroc versus tenofovir/emtricitabine each combined with darunavir/ritonavir for initial HIV-1 treatment

enthalten in: AIDS (London, England) | 2016

von Stellbrink, H. | Le Fevre, E. | Carr, A. | +12

9

Efficacy and safety of grazoprevir (MK-5172) and elbasvir (MK-8742) in patients with hepatitis C virus and HIV co-infection (C-EDGE CO-INFECTION) : a non-randomised, open-label trial

enthalten in: The lancet. HIV | 2015

von Rockstroh, J. | Nelson, M. | Katlama, C. | +16

ErratumIn: Lancet HIV. 2015 Aug;2(8):e316

10

Hepatitis C viremia and the risk of chronic kidney disease in HIV-infected individuals

enthalten in: The Journal of infectious diseases | 2013

von Lucas, G. | Jing, Y. | Sulkowski, M. | +91